Chromogranin A cell density in the large intestine of Asian and European patients with irritable bowel syndrome

References

• El-Salhy M. Recent developments in the pathophysiology of irritable bowel syndrome. World J Gastroenterol. 2015;21:7621–7636.
   PubMed Web of Science ®Google Scholar
• Gwee KA, Lu CL, Ghoshal UC. Epidemiology of irritable bowel syndrome in Asia: something old, something new, something borrowed. J Gastroenterol Hepatol. 2009;24:1601–1607.
   PubMed Web of Science ®Google Scholar
• Hoseini-Asl MK, Amra B. Prevalence of irritable bowel syndrome in Shahrekord, Iran. Indian J Gastroenterol. 2003;22:215–216.
   PubMedGoogle Scholar
• Shah SS, Bhatia SJ, Mistry FP. Epidemiology of dyspepsia in the general population in Mumbai. Indian J Gastroenterol. 2001;20:103–106.
   PubMedGoogle Scholar
• Ghoshal UC, Abraham P, Bhatt C, et al. Epidemiological and clinical profile of irritable bowel syndrome in India: report of the Indian Society of Gastroenterology Task Force. Indian J Gastroenterol. 2008;27:22–28.
   PubMedGoogle Scholar
• Han SH, Lee OY, Bae SC, et al. Prevalence of irritable bowel syndrome in Korea: population-based survey using the Rome II criteria. J Gastroenterol Hepatol. 2006;21:1687–1692.
   PubMed Web of Science ®Google Scholar
• Kwan AC, Hu WH, Chan YK, et al. Prevalence of irritable bowel syndrome in Hong Kong. J Gastroenterol Hepatol. 2002;17:1180–1186.
   PubMed Web of Science ®Google Scholar
• Husain N, Chaudhry IB, Jafri F, et al. A population-based study of irritable bowel syndrome in a non-Western population. Neurogastroenterol Motil. 2008;20:1022–1029.
   PubMed Web of Science ®Google Scholar
• Xiong LS, Chen MH, Chen HX, et al. A population-based epidemiologic study of irritable bowel syndrome in South China: stratified randomized study by cluster sampling. Aliment Pharmacol Ther. 2004;19:1217–1224.
   PubMed Web of Science ®Google Scholar
• Chang FY, Lu CL, Chen TS. The current prevalence of irritable bowel syndrome in Asia. J Neurogastroenterol Motil. 2010;16:389–400.
   PubMedGoogle Scholar
• Karaman N, Turkay C, Yonem O. Irritable bowel syndrome prevalence in city center of Sivas. Turk J Gastroenterol. 2003;14:128–131.
   PubMedGoogle Scholar
• Celebi S, Acik Y, Deveci SE, et al. Epidemiological features of irritable bowel syndrome in a Turkish urban society. J Gastroenterol Hepatol. 2004;19:738–743.
   PubMed Web of Science ®Google Scholar
• Masud MA, Hasan M, Khan AK. Irritable bowel syndrome in a rural community in Bangladesh: prevalence, symptoms pattern, and health care seeking behavior. Am J Gastroenterology. 2001;96:1547–1552.
   PubMed Web of Science ®Google Scholar
• Quigley EM, Locke GR, Mueller-Lissner S, et al. Prevalence and management of abdominal cramping and pain: a multinational survey. Aliment Pharmacol Ther. 2006;24:411–419.
   PubMed Web of Science ®Google Scholar
• Vandvik PO, Lydersen S, Farup PG. Prevalence, comorbidity and impact of irritable bowel syndrome in Norway. Scand J Gastroenterol. 2006;41:650–656.
   PubMed Web of Science ®Google Scholar
• Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Digest Dis Sci. 1993;38:1569–1580.
   PubMed Web of Science ®Google Scholar
• Saito YA, Schoenfeld P, Locke GR. 3rd. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol. 2002;97:1910–1915.
   PubMed Web of Science ®Google Scholar
• Boekema PJ, van Dam van Isselt EF, Bots ML, et al. Functional bowel symptoms in a general Dutch population and associations with common stimulants. Neth J Med. 2001;59:23–30.
   PubMed Web of Science ®Google Scholar
• Agreus L, Svardsudd K, Nyren O, et al. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology. 1995;109:671–680.
   PubMed Web of Science ®Google Scholar
• Hillila MT, Farkkila MA. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population. Aliment Pharmacol Ther. 2004;20:339–345.
   PubMed Web of Science ®Google Scholar
• Kay L, Jorgensen T, Jensen KH. The epidemiology of irritable bowel syndrome in a random population: prevalence, incidence, natural history and risk factors. J Intern Med. 1994;236:23–30.
   PubMed Web of Science ®Google Scholar
• Thompson WG, Irvine EJ, Pare P, et al. Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci. 2002;47:225–235.
   PubMed Web of Science ®Google Scholar
• Boyce PM, Koloski NA, Talley NJ. Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice? Am J Gastroenterology. 2000;95:3176–3183.
   PubMed Web of Science ®Google Scholar
• Mearin F, Badia X, Balboa A, et al. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol 2001;36:1155–1161.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Gundersen D, Hatlebakk JG, Hausken T, Irritable bowel syndrome: diagnosis, pathogenesis and treatment options. New York: Nova Science Publishers, Inc.; 2012.
   Google Scholar
• Taupenot L, Harper KL, O'Connor DT. The chromogranin-secretogranin family. N Engl J Med. 2003;348:1134–1149.
   PubMed Web of Science ®Google Scholar
• Wiedenmann B, Huttner WB. Synaptophysin and chromogranins/secretogranins – widespread constituents of distinct types of neuroendocrine vesicles and new tools in tumor diagnosis. Virchows Arch B Cell Pathol. 1989;58:95–121.
   Google Scholar
• Deftos LJ. Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker. Endocr Rev. 1991;12:181–187.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Lomholt-Beck B, Hausken T. Chromogranin A as a possible tool in the diagnosis of irritable bowel syndrome. Scand J Gastroenterol. 2010;45:1435–1439.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Gilja OH, Gundersen D, et al. Duodenal chromogranin a cell density as a biomarker for the diagnosis of irritable bowel syndrome. Gastroenterol Res Pract. 2014;2014:462856.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Wendelbo I, Gundersen D. Reduced chromogranin A cell density in the ileum of patients with irritable bowel syndrome. Mol Med Rep. 2013;7:1241–1244.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Mazzawi T, Gundersen D, et al. Chromogranin A cell density in the rectum of patients with irritable bowel syndrome. Mol Med Rep. 2012;6:1223–1225.
   PubMed Web of Science ®Google Scholar
• El-Salhy M. Irritable bowel syndrome: diagnosis and pathogenesis. World J Gastroenterol. 2012;18:5151–5163.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Hatlebakk JG, Gilja OH, et al. Irritable bowel syndrome: recent developments in diagnosis, pathophysiology, and treatment. Exp Rev Gastroenterol Hepatol. 2014;8:435–443.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Gundersen D, Gilja OH, et al. Is irritable bowel syndrome an organic disorder? World J Gastroenterol. 2014;20:384–400.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Seim I, Chopin L, et al. Irritable bowel syndrome: the role of gut neuroendocrine peptides. Front Biosci (Elite Ed). 2012;4:2783–2800.
   PubMedGoogle Scholar
• Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. 2006;130:1480–1491.
   PubMed Web of Science ®Google Scholar
• Spiller R, Aziz Q, Creed F, et al. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut. 2007;56:1770–1798.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Sandstrom O, Nasstrom E, et al. Application of computer image analysis in endocrine cell quantification. Histochem J. 1997;29:249–256.
   PubMedGoogle Scholar
• Eiden LE. Is chromogranin a prohormone?. Nature. 1987;325:301
   PubMed Web of Science ®Google Scholar
• Buffa R, Mare P, Gini A, et al. Chromogranins A and B and secretogranin II in hormonally identified endocrine cells of the gut and the pancreas. Basic Appl Histochem. 1988;32:471–484.
   PubMedGoogle Scholar
• Buffa R, Capella C, Fontana P, et al. Types of endocrine cells in the human colon and rectum. Cell Tissue Res. 1978;192:227–240.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Danielsson A, Stenling R, et al. Colonic endocrine cells in inflammatory bowel disease. J Intern Med. 1997;242:413–419.
   PubMed Web of Science ®Google Scholar
• Bishop AE, Pietroletti R, Taat CW, et al. Increased populations of endocrine cells in Crohn’s ileitis. Virchows Arch A Pathol Anat Histopathol. 1987;410:391–396.
   PubMedGoogle Scholar
• El-Salhy M, Mazzawi T, Umezawa K, Gilja OH. Enteroendocrine cells, stem cells and differentiation progenitors in rats with TNBS-induced colitis. Int J Mol Med 2016;38:1743–1751.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Umezawa K. Treatment with novel AP-1 and NF-kappaB inhibitors restores the colonic endocrine cells to normal levels in rats with DSS-induced colitis. Int J Mol Med 2016;37:556–564.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Gundersen D, Hatlebakk JG, et al. Chromogranin a cell density as a diagnostic marker for lymphocytic colitis. Dig Dis Sci. 2012;57:3154–3159.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Lomholt-Beck B, Gundersen TD. High chromogranin A cell density in the colon of patients with lymphocytic colitis. Mol Med Rep. 2011;4:603–605.
   PubMed Web of Science ®Google Scholar
• Egger M, Beer AG, Theurl M, et al. Monocyte migration: a novel effect and signaling pathways of catestatin. Eur J Pharmacol. 2008;598:104–111.
   PubMed Web of Science ®Google Scholar
• Feistritzer C, Mosheimer BA, Colleselli D, et al. Effects of the neuropeptide secretoneurin on natural killer cell migration and cytokine release. Regul Pept. 2005;126:195–201.
   PubMedGoogle Scholar
• Khan WI, Ghia JE. Gut hormones: emerging role in immune activation and inflammation. Clin Exp Immunol. 2010;161:19–27.
   PubMed Web of Science ®Google Scholar
• Margolis KG, Gershon MD. Neuropeptides and inflammatory bowel disease. Curr Opin Gastroenterol. 2009;25:503–511.
   PubMed Web of Science ®Google Scholar
• Bampton PA, Dinning PG. High resolution colonic – amanometry–what have we learnt? – a review of the literature 2012. Curr Gastroenterol Rep. 2013;15:328.
   PubMedGoogle Scholar
• Ameri P, Ferone D. Diffuse endocrine system, neuroendocrine tumors and immunity: what’s new?. Neuroendocrinology. 2012;95:267–276.
   PubMed Web of Science ®Google Scholar
• Farzi A, Reichmann F, Holzer P. The homeostatic role of neuropeptide Y in immune function and its impact on mood and behaviour. Acta Physiol (Oxf). 2015;213:603–627.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Hausken T. The role of the neuropeptide Y (NPY) family in the pathophysiology of inflammatory bowel disease (IBD). Neuropeptides. 2016;55:137–144.
   PubMed Web of Science ®Google Scholar
• Mazzawi T, El-Sahy M, Lied G, Gilja OH, Hatlebakk JG, Hausken T. Effect of fecal transplantation on the symptoms and duodenal endocrine cells in patients with irritable bowel syndrome. UEG J. 2016;4:677.
   PubMed Web of Science ®Google Scholar
• Mazzawi T, Hausken T, Gundersen D, et al. Normalization of large intestinal endocrine cells following dietary management in patients with irritable bowel syndrome. Exp Biol Med. in press.
   Google Scholar
• El-sahy M, Hausken T, Gilja OH, et al. The possible role of gastrointestinal endocrine cells in the pathophysiology of irritable bowel syndrome. Exp Rev Gastroenterol Hepatol. 2016;11:139–148.
   PubMed Web of Science ®Google Scholar
• Ghoshal UC, Shukla R, Ghoshal U, et al. The gut microbiota and irritable bowel syndrome: friend or foe? Int J Inflam. 2012;2012:151085.
   PubMedGoogle Scholar
• Gwee KA. Irritable bowel syndrome in developing countries – a disorder of civilization or colonization?. Neurogastroenterol Motil. 2005;17:317–324.
   PubMed Web of Science ®Google Scholar
• Gonlachanvit S. Are rice and spicy diet good for functional gastrointestinal disorders? J Neurogastroenterol Motil. 2010;16:131–138.
   PubMedGoogle Scholar
• Zuckerman MJ, Guerra LG, Drossman DA, et al. Health-care-seeking behaviors related to bowel complaints. Hispanics versus non-Hispanic whites. Dig Dis Sci. 1996;41:77–82.
   PubMed Web of Science ®Google Scholar